Tara’s beating heart

How Tara’s heart-on-a-chip weeds out cardiac toxicity

Tara Biosystems Inc. is using its heart-on-a-chip platform to uncover cardiac toxicity signals in drug candidates for biopharmas as it ventures into new drug discovery.

Tara’s core technology is a 3-D cardiomyocyte culture system that mimics the electrophysiology and contractile force properties of a human ventricle.

The cardiac muscle cells are derived from induced pluripotent stem (iPS) cells and are suspended by

Read the full 611 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE